Literature DB >> 6750615

Special proliferative sites are not needed for seeding and proliferation of transfused bone marrow cells in normal syngeneic mice.

G Brecher, J D Ansell, H S Micklem, J H Tjio, E P Cronkite.   

Abstract

The widely held view that transfused bone marrow cells will not proliferate in normal mice, not exposed to irradiation or other forms of bone marrow ablation, was reinvestigated. Forty million bone marrow cells from male donors were given to female recipients on each of 5 consecutive days, 5 to 10 times the number customarily used in the past. When the recipients were examined 2-13 weeks after the last transfusion, donor cells were found to average 16-25% of total marrow cells. Similar percentages of donor cells were found when variants of the enzyme phosphoglycerate kinase determined electrophoretically were used for identification of donor and recipient cells. Evidence is presented that the proportion of donor cells is compatible with a linear dependence on the number of cells transfused over the range tested--i.e., 20-200 million bone marrow cells injected intravenously. Special proliferative sites thus do not appear to be required.

Entities:  

Mesh:

Year:  1982        PMID: 6750615      PMCID: PMC346832          DOI: 10.1073/pnas.79.16.5085

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  15 in total

Review 1.  H-Y antigen: behavior and function.

Authors:  W K Silvers; S S Wachtel
Journal:  Science       Date:  1977-03-11       Impact factor: 47.728

2.  Proliferation of donor spleen and bone-marrow cells in the spleens and bone marrows of unirradiated and irradiated adult mice.

Authors:  A Takada; Y Takada; J L Ambrus
Journal:  Proc Soc Exp Biol Med       Date:  1971-01

3.  Fate of chromosome-marked mouse bone marrow cells tranfused into normal syngeneic recipients.

Authors:  H S Micklem; C M Clarke; E P Evans; C E Ford
Journal:  Transplantation       Date:  1968-03       Impact factor: 4.939

4.  Electrophoretic variation for x-chromosome-linked phosphoglycerate kinase (pgk-1) in the mouse.

Authors:  J T Nielsen; V M Chapman
Journal:  Genetics       Date:  1977-10       Impact factor: 4.562

5.  Partitioning of bone marrow into stem cell regulatory domains.

Authors:  M A Maloney; R A Lamela; M J Banda; H M Patt
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

6.  The relationship between the spleen colony-forming cell and the haemopoietic stem cell.

Authors:  R Schofield
Journal:  Blood Cells       Date:  1978

7.  Hematopoietic stem cell proliferative behavior as revealed by bromodeoxyuridine labeling.

Authors:  H M Patt; M A Maloney; R A Lamela
Journal:  Exp Hematol       Date:  1980-09       Impact factor: 3.084

8.  Transplantation of murine bone marrow without prior host irradiation.

Authors:  G Brecher; J H Tjio; J E Haley; J Narla; S L Beal
Journal:  Blood Cells       Date:  1979-06-15

9.  CFUs kinetics observed in vivo by bromodeoxyuridine and near-UV light treatment.

Authors:  M P Hagan; T J MacVittie
Journal:  Exp Hematol       Date:  1981-02       Impact factor: 3.084

10.  Hematopoietic stem cell regulatory volumes as revealed in studies of the bgj/bgj:W/WV chimera.

Authors:  M A Maloney; M J Dorie; R A Lamela; Z R Rogers; H M Patt
Journal:  J Exp Med       Date:  1978-04-01       Impact factor: 14.307

View more
  21 in total

Review 1.  Tolerance induction for solid organ grafts with donor-derived hematopoietic reconstitution.

Authors:  K L Gandy
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

2.  Simultaneous bone marrow and intestine transplantation promotes marrow-derived hematopoietic stem cell engraftment and chimerism.

Authors:  Atsunori Nakao; Hideyoshi Toyokawa; Kei Kimizuka; Michael A Nalesnik; Isao Nozaki; Robert J Bailey; Anthony J Demetris; Thomas E Starzl; Noriko Murase
Journal:  Blood       Date:  2006-04-25       Impact factor: 22.113

Review 3.  The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases.

Authors:  Irving L Weissman; Judith A Shizuru
Journal:  Blood       Date:  2008-11-01       Impact factor: 22.113

4.  HSC niche: ample room for every guest stem cell.

Authors:  Lei Ding
Journal:  Blood       Date:  2017-04-13       Impact factor: 22.113

5.  Busulfan pharmacokinetics, toxicity, and low-dose conditioning for autologous transplantation of genetically modified hematopoietic stem cells in the rhesus macaque model.

Authors:  Elizabeth M Kang; Matthew M Hsieh; Mark Metzger; Allen Krouse; Robert E Donahue; Michel Sadelain; John F Tisdale
Journal:  Exp Hematol       Date:  2006-02       Impact factor: 3.084

6.  Influence of timing of administration of 5-fluorouracil to donors on bone marrow engraftment in nonmyeloablated hosts.

Authors:  L D'Hondt; J Carlson; B Benoit; J Reilly; C Grimaldi; J Wuu; J F Lambert; M S Dooner; P J Quesenberry
Journal:  Int J Hematol       Date:  2001-07       Impact factor: 2.490

Review 7.  Extrinsic regulation of hematopoietic stem cells in development, homeostasis and diseases.

Authors:  Yeojin Lee; Matthew Decker; Heather Lee; Lei Ding
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2017-05-31       Impact factor: 5.814

Review 8.  Low dose total body irradiation followed by allogeneic lymphocyte infusion for refractory hematologic malignancy--an updated review.

Authors:  Karen K Ballen; Gerald Colvin; David Porter; Peter J Quesenberry
Journal:  Leuk Lymphoma       Date:  2004-05

9.  Niche recycling through division-independent egress of hematopoietic stem cells.

Authors:  Deepta Bhattacharya; Agnieszka Czechowicz; A G Lisa Ooi; Derrick J Rossi; David Bryder; Irving L Weissman
Journal:  J Exp Med       Date:  2009-11-02       Impact factor: 14.307

10.  Efficient transplantation via antibody-based clearance of hematopoietic stem cell niches.

Authors:  Agnieszka Czechowicz; Daniel Kraft; Irving L Weissman; Deepta Bhattacharya
Journal:  Science       Date:  2007-11-23       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.